drugset / Trial / NCT03853785

Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts

NCT03853785

Phase 3 Unknown 45 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares the safety and efficacy of intralesional Candidal antigen versus Intralesional MMR vaccine versus podophyllin for treatment of genital warts.

Timeline

Start
2020-02
Primary completion
2021-02
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Candida antigen Vaccine 0.1 ml Other
Comparator Candida antigen Vaccine 0.3 ml Other
Comparator MMR vaccine Vaccine 0.5 ml Other
Comparator Podophyllin Unknown Topical